Renal Cancer - Results from #1860

Sequential immune-targeted surgical therapy resulted in disease-free survival in a case with advanced renal cell carcinoma. September 16, 2021

Renal Tumor Biopsy: Rationale to Avoid Surgery in Small Renal Masses. September 16, 2021

Conditional survival of metastatic clear cell renal cell carcinoma: How prognosis evolves after cytoreductive surgery of primary tumor. September 15, 2021

The prognosis and clinicopathological features of different distant metastases patterns in renal cell carcinoma: analysis based on the SEER database. September 14, 2021

Integrated mRNA and miRNA Transcriptomic Analyses Reveals Divergent Mechanisms of Sunitinib Resistance in Clear Cell Renal Cell Carcinoma (ccRCC). September 14, 2021

A statewide quality improvement collaborative's adherence to the 2017 AUA guidelines regarding initial evaluation of patients with cT1 renal masses. September 13, 2021

p53 is functionally inhibited in clear cell renal cell carcinoma (ccRCC): a mechanistic and correlative investigation into genetic and molecular characteristics. September 13, 2021

The Association of Controlling Nutritional Status (CONUT) Score with Survival in Patients with Surgically Treated Renal Cell Carcinoma and Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis. September 10, 2021

Antioxidant Gene Signature Impacts the Immune Infiltration and Predicts the Prognosis of Kidney Renal Clear Cell Carcinoma. September 10, 2021

Influence of histologic types and subtypes on survival outcomes of intermediate-high and high-risk renal cell carcinoma following nephrectomy: Findings from the SEER database. September 9, 2021

Tumor-infiltrating CD8+ T cells recognize a heterogeneously expressed functional neoantigen in clear cell renal cell carcinoma. September 9, 2021

Immune-related adverse events and kidney function decline in patients with genitourinary cancers treated with immune checkpoint inhibitors. September 8, 2021

Single- versus multi-port robotic partial nephrectomy: a comparative analysis of perioperative outcomes and analgesic requirements. September 8, 2021

P53 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma. September 7, 2021

Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma. September 7, 2021

Provider- and patient-level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma. September 6, 2021

Adjuvant therapy in patients with sarcomatoid RCC: Post hoc analysis from ECOG-ACRIN E2805. September 6, 2021

Serum markers change for intraocular metastasis in renal cell carcinoma. September 3, 2021

Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) for Lenvatinib plus Everolimus Versus Everolimus Monotherapy in Patients with Advanced Renal Cell Carcinoma. September 3, 2021

Optimizing the management of patients with small renal masses in a Canadian context: A Markov decision-analysis model. September 2, 2021

Page 94 of 456